Hero Phase Iii Trial In Advanced Prostate Cancer

HERO phase III trial in advanced prostate cancer

HERO Phase 3 Trial: Relugolix vs. Leuprolide Acetate for Advanced Prostate Cancer

Grand Rounds in Urology

Dr. Shore on the Rationale for the Phase 3 HERO Trial in Advanced Prostate Cancer

HERO Phase 3 Trial: Relugolix vs. Leuprolide Acetate for Advanced Prostate Cancer - Interview

Grand Rounds in Urology

LISTEN: Phase 3 HERO Trial

Grand Rounds in Urology

Dr. Shore on the Objective of the HERO Trial in Advanced Prostate Cancer

HERO: Relugolix versus leuprolide acetate for advanced prostate cancer

Advanced & metastatic prostate cancer at ASCO GU

HERO: relugolix as an oral androgen-deprivation therapy in prostate cancer

Recent trials in advanced prostate cancer: STAMPEDE and AdRad

The HERO Study and the Approval of Relugolix

Grand Rounds in Urology

ESMO 2016: Press brief on the AFFINITY Phase III trial for second-line metastatic prostate cancer

Long term Morbidity Mortality of ADT and Radiation Therapy

Grand Rounds in Urology

ImmunoTherapy - Prostvac phase III Clinical Study for advanced Prostate Cancer

MDV3100 in Advanced Prostate Cancer

Renal & Urology News

Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer

Touch Medical Media

PSMA Targeting for Treatment of Advanced Prostate Cancer - 2021 Prostate Cancer Patient Conference

University of California Television (UCTV)

ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022

European Society for Medical Oncology (ESMO)

Relugolix and Concomitant Treatment for Advanced Prostate Cancer

Grand Rounds in Urology

Burning Questions and Controversies in the Management of Advanced Prostate Cancer Patients

Grand Rounds in Urology